Latest News about ARWR
Recent news which mentions ARWR
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
November 23, 2021
From Benzinga
GlaxoSmithKline Pens $1B Pact For NASH Candidate With Arrowhead
November 23, 2021
From Benzinga
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
November 23, 2021
From Motley Fool
Arrowhead Pharmaceuticals, inc (ARWR) Q4 2021 Earnings Call Transcript
November 22, 2021
Tickers
ARWR
From Motley Fool
Earnings Scheduled For November 22, 2021
November 22, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 18, 2021
From Benzinga
This investor crushes his fund’s benchmark with these 10 stocks
October 12, 2021
From MarketWatch
Here's Why Inhibrx Stock Is on the Move Today
October 12, 2021
From Motley Fool
My 2019 Report Card: Up 319%
August 15, 2021
From Motley Fool
Tickers
ARWR
From Motley Fool
From InvestorPlace
Arrowhead Pharmaceuticals: Buy the Dip?
July 19, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
